The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

In our new series "The Fine Print," ABC News' Dr. Tara Narula breaks down what’s on the labels of over-the-counter drugs, ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...

Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Lawmakers may have had Ivermectin in mind when they passed a law to safeguard doctors who prescribe off-label. But a judge on ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

In response to rising consumer complaints, India's drug regulator is set to implement new labelling norms for medicines that prioritise readability and help make informed choices ...

Concerns over illegible medicine labels are being addressed. The Drugs Consultative Committee is forming a sub-committee.

India's drug regulator is addressing consumer concerns about illegible expiry dates and glossy packaging on medicines by forming a sub-committee. This panel will revamp labeling norms, explore ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...